FDA next week will consider authorizing Pfizer-BioNTech's Covid-19 vaccine for children under 5 years old—even as clinical trials on the shot's efficacy and safety in this age group are ongoing. Here's what health experts say about the balance between needing to protect this critical age group and the potential impact of confusing the public in the process.
A series of recent polls have found that many Americans have grown increasingly frustrated with the pandemic and are pessimistic about its future. See the responses in our interactive charts.
As the Los Angeles Rams and Cincinnati Bengals prepare to face off at Super Bowl LVI this Sunday, health officials around the country are urging caution and suggesting ways to celebrate the event safely amid the Covid-19 pandemic.
FDA fully approves Moderna's Covid-19 vaccine, a study finds moderate-to-severe Covid-19 increases the risk of complications in pregnant individuals, and more in this week's roundup of Covid-19 news.
Pfizer reported $36.8 billion in sales during 2021 for its Covid-19 vaccine, marking the highest sales of any pharmaceutical product in a single year, in today's bite-sized hospital and health industry news from the District of Columbia, Florida, and New York.
